Literature DB >> 20577818

Formation of catalytically active cross-species heterodimers of thymidylate synthase from Plasmodium falciparum and Plasmodium vivax.

Manee Chanama1, Suchart Chanama, Philip J Shaw, Penchit Chitnumsub, Ubolsree Leartsakulpanich, Yongyuth Yuthavong.   

Abstract

Thymidylate synthase (TS) of Plasmodium dihydrofolate reductase-thymidylate synthase (DHFR-TS) functions as a homodimeric enzyme with two active sites located near the subunit interface. The dimerization is essential for catalysis, since the active site of each subunit contains amino acid residues contributed from the other TS domain. In P. falciparum DHFR-TS, it has been shown that the active sites require Cys-490 from one domain and Arg-470 donated from the other domain. Mutants of these two series can complement one another giving rise to active enzyme. Here, the potential to form cross-species heterodimers between P. falciparum and P. vivax TS has been explored. Formation of cross-species heterodimer was tested by co-transformation of TS-inactive Cys-490 mutants of P. falciparum or P. vivax with corresponding TS-inactive Arg-486 mutants of P. vivax or P. falciparum into thymidine-requiring Escherichia coli. Active heterodimers were detected by subunit complementation and 6-[(3)H]-FdUMP binding assays. All combinations of the mutants tested, except for (Pf)R470A+(Pv)C506Y, were able to form catalytically active cross-species heterodimers. The single active site formed by (Pf)R470D+(Pv)C506Y and (Pv)R486D+(Pf)C490A pairs of cross-species heterodimers has k(cat) and K(m) values similar to those of intra-species heterodimers of P. falciparum and P. vivax. This is the first report to demonstrate that the TS subunit interface between Plasmodium species is sufficiently conserved to allow formation of fully active cross-species heterodimer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577818     DOI: 10.1007/s11033-010-0199-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

Review 1.  An overview of chemotherapeutic targets for antimalarial drug discovery.

Authors:  P L Olliaro; Y Yuthavong
Journal:  Pharmacol Ther       Date:  1999-02       Impact factor: 12.310

2.  Pairwise specificity and sequential binding in enzyme catalysis: thymidylate synthase.

Authors:  J S Finer-Moore; W R Montfort; R M Stroud
Journal:  Biochemistry       Date:  1990-07-31       Impact factor: 3.162

3.  Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.

Authors:  Ubolsree Leartsakulpanich; Mallika Imwong; Sasithon Pukrittayakamee; Nicholas J White; Georges Snounou; Worachart Sirawaraporn; Yongyuth Yuthavong
Journal:  Mol Biochem Parasitol       Date:  2002-01       Impact factor: 1.759

4.  Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.

Authors:  P J Houghton; G S Germain; B J Hazelton; J W Pennington; J A Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 5.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

6.  Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum.

Authors:  L Jiang; P C Lee; J White; P K Rathod
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

7.  Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site.

Authors:  C A Schiffer; I J Clifton; V J Davisson; D V Santi; R M Stroud
Journal:  Biochemistry       Date:  1995-12-19       Impact factor: 3.162

8.  Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.

Authors:  P K Rathod; S Reshmi
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate.

Authors:  H A Ingraham; L Dickey; M Goulian
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

Review 10.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

View more
  4 in total

1.  Cloning and heterologous expression of Plasmodium ovale dihydrofolate reductase-thymidylate synthase gene.

Authors:  Srisuda Tirakarn; Pinpunya Riangrungroj; Palangpon Kongsaeree; Mallika Imwong; Yongyuth Yuthavong; Ubolsree Leartsakulpanich
Journal:  Parasitol Int       Date:  2012-01-02       Impact factor: 2.230

2.  Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.

Authors:  Wachiraporn Tipsuwan; Somdet Srichairatanakool; Sumalee Kamchonwongpaisan; Yongyuth Yuthavong; Chairat Uthaipibull
Journal:  Malar J       Date:  2011-05-10       Impact factor: 2.979

3.  Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.

Authors:  Voravuth Somsak; Chairat Uthaipibull; Parichat Prommana; Somdet Srichairatanakool; Yongyuth Yuthavong; Sumalee Kamchonwongpaisan
Journal:  Malar J       Date:  2011-10-07       Impact factor: 2.979

4.  Genome-wide scans for the identification of Plasmodium vivax genes under positive selection.

Authors:  Hai-Mo Shen; Shen-Bo Chen; Yue Wang; Bin Xu; Eniola Michael Abe; Jun-Hu Chen
Journal:  Malar J       Date:  2017-06-06       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.